Executive Dinner Engagement
The Path to Self-Driving: Leveraging Agentic AI to Drive the Future of Clinical Drug Development
000 days 00 hours 00 minutes 00 seconds
Boston, MA, USAMay 19, 20266.00 pm - 9.30 pm
In collaboration with
Register your Interest
Discussion Topics
• Deploying AI technologies to deliver 10X transformation—achieve outcomes autonomously, reduce costs of clinical development, accelerate therapies to market, and lower reliance on multiple eClinical systems.
• How AI-native platforms eclipse legacy solutions, enabling your organisation to increase both study velocity and resource efficiency, facilitating far greater numbers of studies to be run without additional headcount.
• Democratising AI with Medable’s Agent Studio. Empower your teams to build and tailor their own proficient agents without deep technical know-how while integrating internal data and workflows securely.
• Meet agents already primed for orchestration, such as Medable’s CRA, TMF, & PI Summary Agents. See how they assist with risk detection, QTL monitoring, eCOA oversight, and compliance while acting as expert collaborators, not just tools.
Speakers
Luke Bates
VP of Product Management, Enterprise
Andrew Mackinnon
SVP & Executive GM, Customer Value
Agenda
6.00 pm - 7.00 pm
Drinks Reception
7.00 pm - 7.20 pm
Introduction to Medable
7.20 pm - 9.00 pm
Dining experience with table discussions
9.00 pm - 9.30 pm
Closing remarks & key takeaways
Location
At the heart of Boston
Grill 23 has always remained steadfast in its commitment to quality, especially when it comes to its steaks. The restaurant refuses to cut corners, partnering with top-tier purveyors like Brandt Beef—a family-owned California farm known for its sustainable practices and humane animal care.
Brandt Beef is notably the only beef producer in the country to earn the Master Chef’s Institute Seal of Excellence. From Wagyu to American Kobe, Grill 23 takes great pride in the exceptional cuts it serves.
Next Steps
Discussion Topics
• Deploying AI technologies to deliver 10X transformation—achieve outcomes autonomously, reduce costs of clinical development, accelerate therapies to market, and lower reliance on multiple eClinical systems.
• How AI-native platforms eclipse legacy solutions, enabling your organisation to increase both study velocity and resource efficiency, facilitating far greater numbers of studies to be run without additional headcount.
• Democratising AI with Medable’s Agent Studio. Empower your teams to build and tailor their own proficient agents without deep technical know-how while integrating internal data and workflows securely.
• Meet agents already primed for orchestration, such as Medable’s CRA, TMF, & PI Summary Agents. See how they assist with risk detection, QTL monitoring, eCOA oversight, and compliance while acting as expert collaborators, not just tools.
Speakers
Luke Bates
VP of Product Management, Enterprise
Andrew Mackinnon
SVP & Executive GM, Customer Value
Agenda
6.00 pm - 7.00 pm
Drinks Reception
7.00 pm - 7.20 pm
Introduction to Medable
7.20 pm - 9.00 pm
Dining experience with table discussions
9.00 pm - 9.30 pm
Closing remarks & key takeaways
Location
